Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The opioid system in depression
Luke A. Jelen, James Stone, Allan H. Young, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104800-104800
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?
Marjorie R. Levinstein, Reece C. Budinich, Jordi Bonaventura, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 2
A review of the effects of different types of social behaviors on the recruitment of neuropeptides and neurotransmitters in the nucleus accumbens
Johnathan M. Borland
Frontiers in Neuroendocrinology (2025), pp. 101175-101175
Closed Access | Times Cited: 2
Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options
Ane Larrea, Laura Sánchez-Sánchez, Eguzkiñe Díez-Martín, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1727-1727
Open Access | Times Cited: 9
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
Marjorie R. Levinstein, Meghan L. Carlton, Tommaso Di Ianni, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 12, pp. 1118-1126
Open Access | Times Cited: 34
GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review
Robertas Strumila, Aistė Lengvenytė, Sebastien Guillaume, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 29-34
Open Access | Times Cited: 7
Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder
Elliot Hampsey, Luke A. Jelen, Allan H. Young
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 193-204
Open Access | Times Cited: 5
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors
Ivone Gomes, Achla Gupta, Elyssa B. Margolis, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 5, pp. 240-252
Closed Access | Times Cited: 5
The serotonin hypothesis of depression: both long discarded and still supported?
Joanna Moncrieff, Ruth Cooper, Tom Stockmann, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3160-3163
Open Access | Times Cited: 11
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database
Yaqi Zeng, Zhe Chen, Y. Luo, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?
Shaul Schreiber, Lee Keidan, Chaim G. Pick
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 208-208
Open Access
Disrupted intersubject variability architecture in structural and functional brain connectomes in major depressive disorder
Keke Fang, Baohong Wen, Liang Liu, et al.
Psychological Medicine (2025) Vol. 55
Closed Access
Neuroprotective role of geniposide-loaded UMSC nanovesicles in depression via P2ry12 downregulation
Guoxiang Duan, Tianyu Zou, Xue Wu, et al.
Phytomedicine (2025) Vol. 140, pp. 156581-156581
Closed Access
Can dextromethorphan-bupropion reduce mental pain in depressed individuals? A generating hypothesis overview perspective
Maurizio Pompili, Isabella Berardelli, Denise Erbuto, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Reproductive and developmental toxicity assessment of HSK21542, a novel peripherally-restricted kappa opioid receptor agonist in rats and rabbits
Xiaoli Gou, Qidi Ye, Bo Zhi Chen, et al.
Regulatory Toxicology and Pharmacology (2025), pp. 105811-105811
Closed Access
Pharmacological Monotherapy for Depressive Disorders: Current and Future, a Narrative Review
Keming Gao, Evrim Bayrak Oruc, Buket Koparal
Medicina (2025) Vol. 61, Iss. 4, pp. 558-558
Open Access
Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder
Sanjay J. Mathew, Andrew J. Cutler, Nicole C. Visitacion, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Efficacy and safety of hydromorphone for postoperative patient-controlled intravenous analgesia for patients undergoing orthopedic surgery: a randomized, double-blinded controlled trial
Qi Wang, Yuanyuan Zhao, Bin Ling, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Association of Cortical Atrophy Patterns With Clinical Phenotypes and Histopathological Findings in Patients With Rasmussen Syndrome
Tobias Bauer, Nina R. Held, Lennart Walger, et al.
Neurology (2025) Vol. 104, Iss. 10
Closed Access
Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems
Alex I. Wiesman, Jason da Silva Castanheira, Edward A. Fon, et al.
Annals of Neurology (2023) Vol. 95, Iss. 4, pp. 802-816
Open Access | Times Cited: 9
Association between physical activity and depression in adult prescription opioid users: A cross-sectional analysis based on NHANES 2007–2018
Gang� Li, Hongxiang Ji, Qiuxiang Jiang, et al.
General Hospital Psychiatry (2024) Vol. 89, pp. 1-7
Closed Access | Times Cited: 3
Investigating the network ties between affect, attachment, and psychopathology
Jürgen Fuchshuber, Hugo Senra, Henriette Löffler‐Stastka, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 263-273
Open Access | Times Cited: 3
Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
George Anderson
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 350-350
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top